All Reports Events Blogs Videos
Showing 31 results
  • PEAK Matrix®
    July 16, 2026

    Rewards and Recognition (R&R) solutions have become an increasingly strategic component of enterprise talent and employee experience strategies. Organizations are moving beyond transactional recognition programs toward platforms that strengthen culture, reinforce organizational values, improve manager effectiveness,…
  • Blog
    July 08, 2026

    Artificial Intelligence (AI) is having its moment. After years of cautious skepticism, pilot-stage overhang, and boardroom debates, the conversation has moved beyond experimentation. Enterprises are no longer asking whether to deploy agents, they are now asking how fast they can scale them across their entire workflow estate. However, speed comes at a price and almost nobody is doing the math.   The warning signs…
  • Thematic Report
    May 18, 2026

    Mid-market enterprises are increasingly emerging as a strategic growth segment within the Human Capital Management (HCM) landscape as organizations scale operations, formalize HR processes, and modernize workforce management practices. These enterprises are seeking cloud-based platforms that…
  • Provider Compendium
    Dec. 30, 2025

    Enterprises are repositioning quality from a downstream testing activity to a strategic engineering capability embedded across the software development life cycle. As digital, cloud, and AI initiatives scale, expectations are moving beyond defect identification toward resilience,…
  • LinkedIn Live
    Nov. 19, 2025

    In an evolving landscape where analyst relations (AR) shape market perception and business success, leaders continued to look for proven tactics embraced by experienced AR professionals. Everest Group’s Katrina Menzigian, along with industry experts from other…
  • PEAK Matrix®
    Nov. 13, 2025

    Enterprises are elevating quality from a downstream test phase to a strategic engineering discipline woven through the software development life cycle. As digital, cloud, and AI programs scale, expectations shift from defect detection to resilience, velocity,…
  • Viewpoint
    Nov. 10, 2025

    As enterprises accelerate digital transformation and embrace next-generation technologies such as AI, generative AI, and cloud-native platforms, managing quality at scale has become increasingly complex. Traditional tool-centric quality approaches fall short in addressing fragmented processes, inconsistent…
  • PEAK Matrix®
    Oct. 29, 2025

    Enterprises are reimagining quality as a strategic engineering function rather than a downstream testing activity. As a result, demand for specialized Quality Engineering (QE) services is growing rapidly across industries. This analysis shows how the specialists…
  • PEAK Matrix®
    June 09, 2025

    The life sciences industry is undergoing rapid digital transformation, fueled by the need for greater agility, regulatory compliance, and patient-centric operations. Enterprise platforms such as SAP, Oracle, and Salesforce have evolved from back-end systems of record…
  • State of the Market
    May 07, 2025

    The life sciences R&D engine is rapidly digitizing, and clinical development software now sits at its center. This report sizes the global clinical trials technology market at nearly US$6.5 billion for 2025 (8-10% CAGR) and dissects…
  • PEAK Matrix®
    Nov. 11, 2024

    Clinical Trial Management Systems (CTMS) are vital to modern clinical research, offering essential tools to manage and track all operational aspects of the trial process. Clinical trials’ increasing complexity, the growing data volume, and the need…
  • Market Insights™
    Oct. 16, 2024

  • Market Insights™
    Sep. 26, 2024

  • Market Insights™
    Sep. 26, 2024

  • Thematic Report
    Sep. 23, 2024

    In the dynamic life sciences clinical development field, patient engagement has emerged a vital innovation and success driver. As clinical research evolves, integrating patient perspectives and active participation has become a transformative force, significantly enhancing clinical…
  • Viewpoint
    Sep. 05, 2024

    Drug development is a complex, time-consuming, and expensive process. The average cost to develop a new drug has increased from US$1.3 million in 2013 to US$2.3 billion in 2022. This cost increase poses a significant challenge…
  • Viewpoint
    July 03, 2024

    Gen AI can create diverse content and data formats, revolutionizing the AI landscape and transforming businesses. The pharmaceutical industry can use gen AI to sift through vast clinical data volumes, enabling trial protocols’ drafting and improving clinical…
  • Provider Compendium
    Feb. 26, 2024

    Decentralized Clinical Trials (DCTs) are transforming the landscape of clinical research by leveraging digital technologies to facilitate remote patient participation. This patient-centric approach not only benefits participants but also ensures more inclusive and robust study results…
  • PEAK Matrix®
    Dec. 08, 2023

    Decentralized Clinical Trials (DCTs) are transforming the landscape of clinical research by harnessing digital technologies to facilitate remote patient participation. This patient-centric approach not only benefits participants but also ensures more inclusive and robust study results…
  • Provider Compendium
    Aug. 29, 2023

    The pandemic accelerated the need to extract value from data due to the substantial increase in data generation from various clinical sources, characterized by high veracity, variety, and volume. As a result, the adoption of clinical…

Items per page